Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.05 AUD | -2.97% | +5.24% | +49.31% |
03:36am | Bell Potter Downgrades Telix Pharmaceuticals to Hold from Buy, Price Target is AU$14.50 | MT |
04-18 | Jarden Adjusts Telix Pharmaceuticals Price Target to AU$13.52 from AU$13.27, Keeps at Buy | MT |
Evolution of the average Target Price on Telix Pharmaceuticals Limited
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Telix Pharmaceuticals Limited
Jarden Research |
EPS Revisions
- Stock Market
- Equities
- TLX Stock
- Consensus Telix Pharmaceuticals Limited